Measuring heart signals during first Afib ablation
Part of Heart & circulation clinical trials.
This trial is testing a new way to measure electrical signals in the heart during a procedure called pulmonary vein isolation, which treats atrial fibrillation (a type of irregular heartbeat). It is for people who are having this procedure for the first time and whose heart is in a normal rhythm at the time of treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a first-time procedure to treat atrial fibrillation (Afib) by isolating the pulmonary veins.
- You must be 18 years or older and, if female, not pregnant or nursing.
- Your heart must be in a normal rhythm (sinus rhythm) at the time of the procedure.
- You cannot have had a prior ablation procedure for Afib.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new ablation method for people with atrial fibrillation who have not had a prior episode and whose heart tissue shows no low-voltage areas but has a transition zone during mapping. It aims to see if targeting this area improves outcomes.
This trial compares different techniques for a second heart ablation procedure in people with atrial fibrillation (AFib) who have already had one ablation. It aims to find the best approach to stop AFib from coming back.
This trial tests whether reusing special catheters to treat atrial fibrillation is safe, effective, and better for costs and the environment. It may help people with atrial fibrillation who need a procedure called pulmonary vein isolation.
This trial tests a new way to map the heart's electrical signals to help doctors better target and treat atrial fibrillation (an irregular heartbeat). If you're having a procedure to treat AF, this study may help improve the success of your treatment.
This trial tests a new method called pulsed field ablation (PFA) to treat irregular heartbeats (atrial fibrillation) by isolating the veins that carry blood to your heart. It aims to see how well this procedure works and if it's safe for you.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.